RPL15P5

Across TCGA pan-cancer cohorts, RPL15P5 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RPL15P5 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RPL15P5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL15P5 expression acts as an unfavorable survival marker, although some lineages such as READ and LUSC show a favorable association.

LIHC, ACC, and KIRC are the cancer types where RPL15P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	III,IV	0.194	0.582	<.001	74	view →
ACC	DFS	Median	All	0.270	0.609	.001	61	view →
KIRC	DFS	Tertile	IV	0.480	0.728	.007	40	view →
BLCA	DFS	Quartile	III,IV	0.348	0.633	.009	36	view →
READ	DFS	Quartile	III,IV	0.977	0.327	.006	31	view →
LUSC	DFS	Median	II,III,IV	0.671	0.517	.009	25	view →
UCS	DFS	Tertile	III,IV	0.529	0.215	.020	22	view →
PAAD	OS	Tertile	All	0.376	0.569	.003	22	view →
PRAD	DFS	Tertile	All	0.650	0.880	.006	18	view →
LUAD	DFS	Median	IV	0.753	0.321	.015	18	view →
KICH	DFS	Tertile	All	0.635	1.000	.012	18	view →
KIRP	DFS	Median	III,IV	0.152	0.570	.014	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RPL15P5–LIHC (OS)

Open the LIHC breakdown →